These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33569752)

  • 21. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
    Mizoguchi M; Tahara N; Tahara A; Nitta Y; Kodama N; Oba T; Mawatari K; Yasukawa H; Kaida H; Ishibashi M; Hayabuchi N; Harada H; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1110-8. PubMed ID: 21999871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should vascular wall
    Lensen KDF; Voskuyl AE; Comans EFI; van der Laken CJ; Boellaard R; Smulders YM
    Int J Cardiovasc Imaging; 2020 Mar; 36(3):545-551. PubMed ID: 31898005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atorvastatin Reduces Circulating S100A12 Levels in Patients with Carotid Atherosclerotic Plaques - A Link with Plaque Inflammation.
    Komatsu T; Ayaori M; Uto-Kondo H; Hayashi K; Tamura K; Sato H; Sasaki M; Nishida T; Takiguchi S; Yakushiji E; Nakaya K; Ikewaki K
    J Atheroscler Thromb; 2022 May; 29(5):775-784. PubMed ID: 33952812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDG PET/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma: A retrospective cohort study.
    Lawal IO; Orunmuyi AT; Popoola GO; Lengana T; Mokoala KMG; Ankrah AO; Sathekge MM
    Medicine (Baltimore); 2020 Nov; 99(48):e23259. PubMed ID: 33235083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
    Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A
    Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
    deGoma EM; Salavati A; Shinohara RT; Saboury B; Pollan L; Schoen M; Torigian DA; Mohler ER; Dunbar RL; Litt HI; Woo J; Rader DJ; Alavi A; Mehta NN
    Acad Radiol; 2015 May; 22(5):600-9. PubMed ID: 25708866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arterial wall inflammation assessed by 18F-FDG-PET/CT is higher in individuals with Type 1 diabetes and associated with circulating inflammatory proteins.
    Janssen AWM; van Heck JIP; Stienstra R; Aarntzen EHJG; van Diepen JA; Riksen NP; Tack CJ
    Cardiovasc Res; 2023 Aug; 119(10):1942-1951. PubMed ID: 37079728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease.
    Verweij SL; Duivenvoorden R; Stiekema LCA; Nurmohamed NS; van der Valk FM; Versloot M; Verberne HJ; Stroes ESG; Nahrendorf M; Bekkering S; Bernelot Moens SJ
    Cardiovasc Res; 2018 Mar; 114(3):468-475. PubMed ID: 29186373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular Positron Emission Tomography and Restenosis in Symptomatic Peripheral Arterial Disease: A Prospective Clinical Study.
    Chowdhury MM; Tarkin JM; Albaghdadi MS; Evans NR; Le EPV; Berrett TB; Sadat U; Joshi FR; Warburton EA; Buscombe JR; Hayes PD; Dweck MR; Newby DE; Rudd JHF; Coughlin PA
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):1008-1017. PubMed ID: 31202739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
    Nahrendorf M; Keliher E; Panizzi P; Zhang H; Hembrador S; Figueiredo JL; Aikawa E; Kelly K; Libby P; Weissleder R
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1213-22. PubMed ID: 19833312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing Semiquantitative and Qualitative Methods of Vascular
    Dashora HR; Rosenblum JS; Quinn KA; Alessi H; Novakovich E; Saboury B; Ahlman MA; Grayson PC
    J Nucl Med; 2022 Feb; 63(2):280-286. PubMed ID: 34088771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclinical systemic and vascular inflammation detected by (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with mild psoriasis.
    Youn SW; Kang SY; Kim SA; Park GY; Lee WW
    J Dermatol; 2015 Jun; 42(6):559-66. PubMed ID: 25807844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appearance of aseptic vascular grafts after endovascular aortic repair on [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography.
    Bennett P; Tomas MB; Koch CF; Nichols KJ; Palestro CJ
    World J Radiol; 2023 Aug; 15(8):241-249. PubMed ID: 37662425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
    Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point
    Kang MK; Kim CJ; Choo EH; Han EJ; Hwang BH; Kim JJ; Kim SH; O JH; Chang K
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1745-1753. PubMed ID: 31312997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.
    Bala G; Blykers A; Xavier C; Descamps B; Broisat A; Ghezzi C; Fagret D; Van Camp G; Caveliers V; Vanhove C; Lahoutte T; Droogmans S; Cosyns B; Devoogdt N; Hernot S
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):1001-8. PubMed ID: 26800768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography.
    Kim TN; Kim S; Yang SJ; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Circ Cardiovasc Imaging; 2010 Mar; 3(2):142-8. PubMed ID: 20061516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of triple disease modifying anti-rheumatic drug therapy on carotid artery inflammation in drug-naive patients with recent onset of rheumatoid arthritis.
    Haavisto M; Saraste A; Pirilä L; Hannukainen JC; Kalliokoski KK; Kirjavainen A; Kemppainen J; Möttönen T; Knuuti J; Yli-Kerttula T; Roivainen A
    Rheumatology (Oxford); 2016 Oct; 55(10):1777-85. PubMed ID: 27330160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.